1-3 of 3
Abraham Sunder Singh
Close
Sort by
Journal Articles

Assessment of Transduction of CD34+ Human Hematopoietic Stem Cells from Patients with Severe Hemophilia-Α with Lentiviral Vector Carrying a High Expression FVIII Transgene (CD68-ET3-LV)

Gurbind Singh, Mohanashankar A M, Shaji R Velayudhan, Gabriela Denning, Abraham Sunder Singh, Anbu Jeba, Aby Abraham, Christopher B Doering, H Trent Spencer, Alok Srivastava
Journal: Blood
Blood (2023) 142 (Supplement 1): 481.
https://doi.org/10.1182/blood-2023-188513
Published: 2023
Journal Articles

Outcome of Immune Tolerance Induction Using an Extended Half-Life Clotting Factor Concentrate — Recombinant Factor VIII Fc (Eloctate™) — a Report from India

Aby Abraham, MD DM, Shashikant Apte, MD FRCPA, Chandrakala Shamukhaiah, MD DM, Fouzia N., DNB, DM, Kannan Subramaniam, DNB, DM, Akshata Rahate, MD DM, Abraham Sunder Singh, BSc, Aditi Joshi, BAMS, Kavitha M Lakshmi, MSc, Rajesh Phatale, MD, Shrimati Shetty, PhD, Sukesh Chandran Nair, MD, Biju George, DM, Vikram Mathews, MD, Alok Srivastava, MD, FRACP,FRCPA
Journal: Blood
Blood (2018) 132 (Supplement 1): 2494.
https://doi.org/10.1182/blood-2018-99-119279
Published: 2018
Journal Articles

Meaningful Reduction of Annual Bleeding Rate with Lower Dose Prophylaxis in Minimally Treated Children with Hemophilia in India

Aby Abraham, MD DM, Shashikant Apte, MD FRCPA, Abraham Sunder Singh, BSc, Kannan Subramaniam, DNB, DM, Anu Korula, MD DM, Aditi Joshi, BAMS, Dipti Khedekar, BA, Kavitha M Lakshmi, MSc, Biju George, MDDM, Vikram Mathews, MD DM, Alok Srivastava, MD
Journal: Blood
Blood (2017) 130 (Supplement 1): 1079.
https://doi.org/10.1182/blood.V130.Suppl_1.1079.1079
Published: 2017